Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study
Episodes of vomiting are most common during the initiation phase and following dose increases, with frequency and severity typically decreasing over time
A popular combination approach uses 27 mg GHK-Cu + 10 mg TB-500 + 5 mg BPC-157, dosed at 0.9-1.8 mg of the blend daily for 6 weeks
Theres very few, if not only one, human trial that was a retrospective study, looking at knee pain, and they injected people with BPC-157
Consequently, the difference observed in administration site events may reflect differences in individual reporting tendencies
The freedom from carrying excess weight, both physically and psychologically, opens doors that felt closed before